Dustin T. King

Dustin T. King

Auto-generated profile, based on publicly available information

Dustin T. King

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DKDustin T. King
Dustin T. King
JSJesus Emanauel Serrano-Negron
Jesus Emanauel Serrano-Negron
YZYanping Zhu
Yanping Zhu
CMChristopher L. Moore
Christopher L. Moore
MSMatthew D. Shoulders
Matthew D. Shoulders
DVDavid J. Vocadlo
David J. Vocadlo

16 June 2022 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
DKDustin T. King
Dustin T. King
SZSha Zhu
Sha Zhu
DHDarryl B. Hardie
Darryl B. Hardie
JSJesus Emanauel Serrano-Negron
Jesus Emanauel Serrano-Negron
ZMZarina Madden
Zarina Madden
DVDavid J. Vocadlo
David J. Vocadlo

20 September 2024 in ACS Catalysis
Verified
Journal Article
Open access
SBSandeep Bhosale
Sandeep Bhosale
SKSachin Kandalkar
Sachin Kandalkar
PGPierre-André Gilormini
Pierre-André Gilormini
OAOluwafemi Akintola
Oluwafemi Akintola
RRRhianna Rowland
Rhianna Rowland
ABAndrew James Bennet
Andrew James Bennet
Mutations in many members of the set of human lysosomal glycoside hydrolases cause a wide range of lysosomal storage diseases. As a result, much effort has been directed toward identifying pharmacological chaperones of these lysosomal enzymes. The majority of the candidate chaperones are active site-directed competitive iminosugar inhibitors but these have met with limited success. As a first step toward an alternative class of pharmacological chaperones we explored the potential of small molecule mechanism-based reversible covalent inhibitors to form transient enzyme–inhibitor adducts. By serial synthesis and kinetic analysis of candidate molecules, we show that rational tuning of the chemical reactivity of glucose-configured carbasugars delivers cyclohexenyl-based allylic carbasugar that react with the lysosomal enzyme β-glucocerebrosidase (GCase) to form covalent enzyme-adducts with different half-lives. X-ray structural analysis of these compounds bound noncovalently to GCase, along with the structures of the covalent adducts of compounds that reacted with the catalytic nucleophile of GCase, reveal unexpected reactivities of these compounds. Using differential scanning fluorimetry, we show that formation of a transient covalent intermediate stabilizes the folded enzyme against thermal denaturation. In addition, these covalent adducts break down to liberate the active enzyme and a product that is no longer inhibitory. We further show that the one compound, which reacts through an unprecedented SN1′-like mechanism, exhibits exceptional reactivity–illustrated by this compound also covalently labeling an α-glucosidase. We anticipate that such carbasugar-based single turnover covalent ligands may serve as pharmacological chaperones for lysosomal glycoside hydrolases and other disease-associated retaining glycosidases. The unusual reactivity of these molecules should also open the door to creation of new chemical biology probes to explore the biology of this important superfamily of glycoside hydrolases.

7 July 2023 in Chemistry – A European Journal
Verified
Journal Article
Closed access
RARoger A. Ashmus
Roger A. Ashmus
YWYang Wang
Yang Wang
MGManuel González‐Cuesta
Manuel González‐Cuesta
DKDustin T. King
Dustin T. King
BTBen Tiet
Ben Tiet
DVDavid J. Vocadlo
David J. Vocadlo

25 June 2026 in Analytical Chemistry
Verified
Journal Article
Closed access
JBJun Bian
Jun Bian
JRJason C. Rogalski
Jason C. Rogalski
YLYongmei Lyu
Yongmei Lyu
YWYaqing Wang
Yaqing Wang
JSJesus Emanauel Serrano-Negron
Jesus Emanauel Serrano-Negron
JVJosef Voglmeir
Josef Voglmeir